|
EspAddText
EspRemoveText
|
Health and health care for an aging population
|
Policy document
|
2018
|
|
EspAddText
EspRemoveText
|
Tamper Resistance under the Controlled Drugs and Substances Act
|
Response to consultation
|
2014
|
|
EspAddText
EspRemoveText
|
Appropriateness in health care
|
Policy document
|
2020
|
|
EspAddText
EspRemoveText
|
Complementary and alternative medicine (update 2015)
|
Policy document
|
2015
|
|
EspAddText
EspRemoveText
|
Regulatory framework for the mandatory reporting of adverse drug reactions and medical device incidents by provincial and territorial healthcare institutions.
|
Response to consultation
|
2016
|
|
EspAddText
EspRemoveText
|
Joint Canadian Medical Association & Canadian Psychiatric Association Policy - Access to mental health care
|
Policy document
|
2016
|
|
EspAddText
EspRemoveText
|
Front-of-package labelling consultation
|
Response to consultation
|
2016
|
|
EspAddText
EspRemoveText
|
Regulation of Self-Care Products in Canada
|
Response to consultation
|
2016
|
|
EspAddText
EspRemoveText
|
Consultation on the renewal of Federal Tobacco Control Strategy
|
Response to consultation
|
2017
|
|
EspAddText
EspRemoveText
|
Health Canada’s Consultation on “Plain and Standardized Packaging”
|
Response to consultation
|
2016
|
|
EspAddText
EspRemoveText
|
Consultation on proposed front-of-package labelling
|
Response to consultation
|
2018
|
|
EspAddText
EspRemoveText
|
Health Canada consultation on tobacco products regulations (plain and standardized appearance)
|
Response to consultation
|
2018
|
|
EspAddText
EspRemoveText
|
Implementation of National Pharmacare
|
Response to consultation
|
2018
|
|
EspAddText
EspRemoveText
|
Health Canada’s consultation on new health-related labelling for tobacco products
|
Response to consultation
|
2018
|
|
EspAddText
EspRemoveText
|
Health Canada consultation on the impact of vaping products advertising on youth and non-users of tobacco products
|
Response to consultation
|
2019
|
|
EspAddText
EspRemoveText
|
Concussion in Sport, Leisure, and Occupational Settings
|
Policy document
|
2019
|
|
EspAddText
EspRemoveText
|
Antimicrobial Resistance (AMR)
|
Policy document
|
2019
|
|
EspAddText
EspRemoveText
|
Health Canada consultation on vaping products labelling and packaging regulations
|
Response to consultation
|
2019
|
|
EspAddText
EspRemoveText
|
Health Canada consultation on potential market for cannabis health products that would not require practitioner oversight
|
Response to consultation
|
2019
|
|
EspAddText
EspRemoveText
|
Organ and tissue donation and transplantation
|
Policy document
|
2019
|